开云app官网登录入口网页版-官方正版

#宫颈#

482篇内容 | 4476人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2177164, encodeId=843e21e716498, content=<a href='/topic/show?id=df6645135f7' target=_blank style='color:#2F92EE;'>#子宫#</a> <a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=注意！宫颈这种影像表现，不要勿判为异常！, objectType=article, longId=806874, objectId=1cf68068e41b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-examining-an-x-ray-4T9YEHV.jpg, objectUrl=/article/show_article.do?id=1cf68068e41b, replyNumber=0, likeNumber=78, createdTime=2023-12-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1cf68068e41b, moduleTitle=注意！宫颈这种影像表现，不要勿判为异常！, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1cf68068e41b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1408356, encodeId=946014083562c, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=首个国产二价HPV疫苗3期临床结果发布：100%预防宫颈癌前病变, objectType=article, longId=737411, objectId=5c71e3741118, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c71e3741118, replyNumber=0, likeNumber=68, createdTime=2022-09-01, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c71e3741118, moduleTitle=首个国产二价HPV疫苗3期临床结果发布：100%预防宫颈癌前病变, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5c71e3741118)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408355, encodeId=a6c0140835516, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=Clin Trans Gastroenterology：炎症性肠病会轻度增加宫颈癌的风险, objectType=article, longId=732653, objectId=29b1e326532e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29b1e326532e, replyNumber=0, likeNumber=86, createdTime=2022-07-19, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29b1e326532e, moduleTitle=Clin Trans Gastroenterology：炎症性肠病会轻度增加宫颈癌的风险, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=29b1e326532e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408354, encodeId=0845140835448, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=中国生物11价HPV疫苗预防宫颈癌3期临床试验已启动, objectType=article, longId=728562, objectId=661ee2856268, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661ee2856268, replyNumber=0, likeNumber=0, createdTime=2022-06-04, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661ee2856268, moduleTitle=中国生物11价HPV疫苗预防宫颈癌3期临床试验已启动, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=661ee2856268)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408353, encodeId=74fb140835338, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性, objectType=article, longId=728373, objectId=4ee9e283734e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee9e283734e, replyNumber=0, likeNumber=85, createdTime=2022-06-02, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee9e283734e, moduleTitle=J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4ee9e283734e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408352, encodeId=af53140835257, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=J Clin Oncol：大多数2-3级宫颈上皮内瘤变（CIN2/3）不需要治疗, objectType=article, longId=726679, objectId=473de266790c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=473de266790c, replyNumber=0, likeNumber=83, createdTime=2022-05-13, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=473de266790c, moduleTitle=J Clin Oncol：大多数2-3级宫颈上皮内瘤变（CIN2/3）不需要治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=473de266790c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408351, encodeId=48621408351f3, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=BMJ：澳大利亚近400万HPV疫苗接种人群进行初级宫颈癌筛查头两年的全国经验, objectType=article, longId=723489, objectId=0e6de23489a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e6de23489a1, replyNumber=0, likeNumber=92, createdTime=2022-04-06, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e6de23489a1, moduleTitle=BMJ：澳大利亚近400万HPV疫苗接种人群进行初级宫颈癌筛查头两年的全国经验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0e6de23489a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408350, encodeId=af7c1408350ef, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败, objectType=article, longId=302279, objectId=6eee3022e979, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6eee3022e979, replyNumber=0, likeNumber=87, createdTime=2022-04-04, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6eee3022e979, moduleTitle=度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6eee3022e979)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408349, encodeId=b00214083493b, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, objectType=article, longId=302023, objectId=f6e5302023a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e5302023a2, replyNumber=0, likeNumber=105, createdTime=2022-04-01, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e5302023a2, moduleTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f6e5302023a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408348, encodeId=54be140834880, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=European Radiology：MRI衍生的放射组学分析实现了早期宫颈癌的无创评估, objectType=article, longId=300577, objectId=a7163005e7bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7163005e7bd, replyNumber=0, likeNumber=86, createdTime=2022-03-14, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7163005e7bd, moduleTitle=European Radiology：MRI衍生的放射组学分析实现了早期宫颈癌的无创评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a7163005e7bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408347, encodeId=7db4140834e67, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=J Clin Oncol：信迪利单抗联合安罗替尼治疗PD-L1阳性晚期宫颈癌, objectType=article, longId=299549, objectId=91b029954956, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=91b029954956, replyNumber=0, likeNumber=99, createdTime=2022-02-25, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=91b029954956, moduleTitle=J Clin Oncol：信迪利单抗联合安罗替尼治疗PD-L1阳性晚期宫颈癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=91b029954956)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408346, encodeId=8249140834656, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=IJMI：筛查准确率高达92.1%！大数据助力宫颈癌筛查, objectType=article, longId=295630, objectId=4d2c295630b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d2c295630b3, replyNumber=0, likeNumber=0, createdTime=2022-02-16, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d2c295630b3, moduleTitle=IJMI：筛查准确率高达92.1%！大数据助力宫颈癌筛查, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=4d2c295630b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408345, encodeId=a500140834556, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=NEJM：采用Cemiplimab治疗复发性宫颈癌, objectType=article, longId=295537, objectId=c58b29553e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c58b29553e6f, replyNumber=0, likeNumber=75, createdTime=2022-02-14, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c58b29553e6f, moduleTitle=NEJM：采用Cemiplimab治疗复发性宫颈癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c58b29553e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408344, encodeId=d05b140834441, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=Front Oncol：宫颈癌根治性子宫切除术+淋巴结清扫(RHND)+辅助放疗(RT)/同步放化疗(CCRT)后复发患者的复发模式及预后因素, objectType=article, longId=295136, objectId=26002951366f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26002951366f, replyNumber=0, likeNumber=81, createdTime=2022-02-06, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26002951366f, moduleTitle=Front Oncol：宫颈癌根治性子宫切除术+淋巴结清扫(RHND)+辅助放疗(RT)/同步放化疗(CCRT)后复发患者的复发模式及预后因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=26002951366f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408343, encodeId=eddd1408343f5, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=Front Oncol：奈达铂 vs 顺铂为基础的同期放化疗治疗IIB-IVA期宫颈癌患者的疗效和安全性, objectType=article, longId=295133, objectId=e466295133ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e466295133ba, replyNumber=0, likeNumber=81, createdTime=2022-02-06, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e466295133ba, moduleTitle=Front Oncol：奈达铂 vs 顺铂为基础的同期放化疗治疗IIB-IVA期宫颈癌患者的疗效和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e466295133ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408342, encodeId=5bb7140834207, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=赛诺菲（Sanofi）和再生元（Regeneron）撤销关于Libtayo治疗宫颈癌的申请, objectType=article, longId=295109, objectId=a25b295109ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a25b295109ad, replyNumber=0, likeNumber=115, createdTime=2022-02-05, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a25b295109ad, moduleTitle=赛诺菲（Sanofi）和再生元（Regeneron）撤销关于Libtayo治疗宫颈癌的申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a25b295109ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408341, encodeId=f93c1408341aa, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=中国实用妇科与产科杂志：子宫颈癌手术治疗质量控制标准中国专家共识QM-C2型广泛性子宫切除篇, objectType=article, longId=294405, objectId=cb7429440546, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb7429440546, replyNumber=0, likeNumber=79, createdTime=2022-01-22, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb7429440546, moduleTitle=中国实用妇科与产科杂志：子宫颈癌手术治疗质量控制标准中国专家共识QM-C2型广泛性子宫切除篇, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cb7429440546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408340, encodeId=d813140834072, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=吴小华教授：2021年度宫颈癌诊治年度进展, objectType=article, longId=293804, objectId=51fa29380403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51fa29380403, replyNumber=0, likeNumber=73, createdTime=2022-01-12, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51fa29380403, moduleTitle=吴小华教授：2021年度宫颈癌诊治年度进展, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=51fa29380403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408339, encodeId=0b3f1408339ba, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系, objectType=article, longId=293511, objectId=c36c2935113d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c36c2935113d, replyNumber=0, likeNumber=80, createdTime=2022-01-07, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c36c2935113d, moduleTitle=JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=c36c2935113d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1408338, encodeId=d2b2140833804, content=<a href='/topic/show?id=92194628826' target=_blank style='color:#2F92EE;'>#宫颈#</a>, objectTitle=Cell Death Differ：HPV介导EGFR信号转导通路促进宫颈癌细胞的增殖, objectType=article, longId=293042, objectId=5ca22930427c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ca22930427c, replyNumber=0, likeNumber=72, createdTime=2021-12-30, rootId=0, userName=一闲, userId=11102737131, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ca22930427c, moduleTitle=Cell Death Differ：HPV介导EGFR信号转导通路促进宫颈癌细胞的增殖, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5ca22930427c)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

宫颈

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#子宫# #宫颈#

注意！宫颈这种影像表现，不要勿判为异常！

2023-12-25发表于上海

一闲 (审核中...)

前往app查看评论内容

#宫颈#

首个国产二价HPV疫苗3期临床结果发布：100%预防宫颈癌前病变

2022-09-01

一闲 (审核中...)

前往app查看评论内容

#宫颈#

Clin Trans Gastroenterology：炎症性肠病会轻度增加宫颈癌的风险

2022-07-19

一闲 (审核中...)

前往app查看评论内容

#宫颈#

中国生物11价HPV疫苗预防宫颈癌3期临床试验已启动

2022-06-04

一闲 (审核中...)

前往app查看评论内容

#宫颈#

J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性

2022-06-02

一闲 (审核中...)

前往app查看评论内容

#宫颈#

J Clin Oncol：大多数2-3级宫颈上皮内瘤变（CIN2/3）不需要治疗

2022-05-13

一闲 (审核中...)

前往app查看评论内容

#宫颈#

BMJ：澳大利亚近400万HPV疫苗接种人群进行初级宫颈癌筛查头两年的全国经验

2022-04-06

一闲 (审核中...)

前往app查看评论内容

#宫颈#

度伐利尤单抗治疗局部晚期宫颈癌III期研究，结果失败

2022-04-04

一闲 (审核中...)

前往app查看评论内容

#宫颈#

BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果

2022-04-01

一闲 (审核中...)

前往app查看评论内容

#宫颈#

European Radiology：MRI衍生的放射组学分析实现了早期宫颈癌的无创评估

2022-03-14

一闲 (审核中...)

前往app查看评论内容

#宫颈#

J Clin Oncol：信迪利单抗联合安罗替尼治疗PD-L1阳性晚期宫颈癌

2022-02-25

一闲 (审核中...)

前往app查看评论内容

#宫颈#

IJMI：筛查准确率高达92.1%！大数据助力宫颈癌筛查

2022-02-16

一闲 (审核中...)

前往app查看评论内容

#宫颈#

NEJM：采用Cemiplimab治疗复发性宫颈癌

2022-02-14

一闲 (审核中...)

前往app查看评论内容

#宫颈#

Front Oncol：宫颈癌根治性子宫切除术+淋巴结清扫(RHND)+辅助放疗(RT)/同步放化疗(CCRT)后复发患者的复发模式及预后因素

2022-02-06

一闲 (审核中...)

前往app查看评论内容

#宫颈#

Front Oncol：奈达铂 vs 顺铂为基础的同期放化疗治疗IIB-IVA期宫颈癌患者的疗效和安全性

2022-02-06

一闲 (审核中...)

前往app查看评论内容

#宫颈#

赛诺菲（Sanofi）和再生元（Regeneron）撤销关于Libtayo治疗宫颈癌的申请

2022-02-05

一闲 (审核中...)

前往app查看评论内容

#宫颈#

中国实用妇科与产科杂志：子宫颈癌手术治疗质量控制标准中国专家共识QM-C2型广泛性子宫切除篇

2022-01-22

一闲 (审核中...)

前往app查看评论内容

#宫颈#

吴小华教授：2021年度宫颈癌诊治年度进展

2022-01-12

一闲 (审核中...)

前往app查看评论内容

#宫颈#

JAMA Netw Open：母亲宫颈疾病与后代人乳头瘤病毒疫苗接种的关系

2022-01-07

一闲 (审核中...)

前往app查看评论内容

#宫颈#

Cell Death Differ：HPV介导EGFR信号转导通路促进宫颈癌细胞的增殖

2021-12-30

科室
- - 订阅+
  - 更多科室
工具
服务